From: Cardiovascular magnetic resonance imaging characteristics in patients with methamphetamine-associated cardiomyopathy
Metamphetamine cessation
(n = 11)
Continued metamphetamine use
(n = 13)
p-value
Change in EF, %
16 (5 to 22)
3.1 (− 12 to 34)
0.003